Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16449473
Conclusion of this study
No differences were found in primary pairwise comparison analyses of open-label augmentation with lamotrigine, inositol, or risperidone. Post hoc secondary analyses suggest that lamotrigine may be superior to inositol and risperidone in improving treatment-resistant bipolar depression.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
